Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Renz

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Patient Preferences for Endometriosis Pain Treatments in the United StatesChristine Poulos, Ahmed M Soliman, Cheryl L Renz, et al.
Critical Care Medicine|October 3, 1999
Antihistamine prophylaxis permits rapid vancomycin infusionC L Renz, J D Thurn, H A Finn, et al.
Anesthesia and Analgesia|September 5, 1998
Oral antihistamines reduce the side effects from rapid vancomycin infusionC L Renz, J D Thurn, H A Finn, et al.
Drug Safety|May 14, 2021
Risk Minimization of Antibody-Drug Conjugates in Oncology: A ReviewFabio A Lievano, Linda J Scarazzini, Jerzy E Tyczynski, et al.
Anesthesiology|September 22, 1998
Tryptase levels are not increased during vancomycin-induced anaphylactoid reactionsC L Renz, D Laroche, J D Thurn, et al.
Dalton Transactions (Cambridge, England : 2003)|January 5, 2011
Combined experimental and theoretical investigation into C-H activation of cyclic alkanes by Cp'Rh(CO)2 (Cp' = η5-C5H5 or η5-C5Me5)Michael W George, Michael B Hall, Peter Portius, et al.
Clinical Therapeutics|December 13, 2006
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trialAlan Kivitz, Steven Cohen, James Edward Dowd, et al.
The New England Journal of Medicine|September 8, 2010
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjectsW Philip T James, Ian D Caterson, Walmir Coutinho, et al.
Annals of Internal Medicine|July 19, 2006
Effects of sibutramine treatment in obese adolescents: a randomized trialRobert I Berkowitz, Ken Fujioka, Stephen R Daniels, et al.
Diabetes, Obesity & Metabolism|December 24, 2011
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trialI D Caterson, N Finer, W Coutinho, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 15, 2019
Patient Preferences for Endometriosis Pain Treatments in the United StatesChristine Poulos, Ahmed M Soliman, Cheryl L Renz, et al.
Critical Care Medicine|October 3, 1999
Antihistamine prophylaxis permits rapid vancomycin infusionC L Renz, J D Thurn, H A Finn, et al.
Anesthesia and Analgesia|September 5, 1998
Oral antihistamines reduce the side effects from rapid vancomycin infusionC L Renz, J D Thurn, H A Finn, et al.
Drug Safety|May 14, 2021
Risk Minimization of Antibody-Drug Conjugates in Oncology: A ReviewFabio A Lievano, Linda J Scarazzini, Jerzy E Tyczynski, et al.
Anesthesiology|September 22, 1998
Tryptase levels are not increased during vancomycin-induced anaphylactoid reactionsC L Renz, D Laroche, J D Thurn, et al.
Dalton Transactions (Cambridge, England : 2003)|January 5, 2011
Combined experimental and theoretical investigation into C-H activation of cyclic alkanes by Cp'Rh(CO)2 (Cp' = η5-C5H5 or η5-C5Me5)Michael W George, Michael B Hall, Peter Portius, et al.
Clinical Therapeutics|December 13, 2006
Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trialAlan Kivitz, Steven Cohen, James Edward Dowd, et al.
The New England Journal of Medicine|September 8, 2010
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjectsW Philip T James, Ian D Caterson, Walmir Coutinho, et al.
Annals of Internal Medicine|July 19, 2006
Effects of sibutramine treatment in obese adolescents: a randomized trialRobert I Berkowitz, Ken Fujioka, Stephen R Daniels, et al.
Diabetes, Obesity & Metabolism|December 24, 2011
Maintained intentional weight loss reduces cardiovascular outcomes: results from the Sibutramine Cardiovascular OUTcomes (SCOUT) trialI D Caterson, N Finer, W Coutinho, et al.
Pageof 3